Ceribell Inc.
XNAS:CBLL 4:00:00 PM EDT
| Market Cap (Intraday) | 713.32M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $18.28 |
| 50-Day MA | $19.16 |
| 200-Day MA | $16.95 |
Ceribell Inc. Stock, XNAS:CBLL
360 North Pastoria Avenue, Sunnyvale, California 94085
United States of America
Phone: +1.800.436.0826
Number of Employees: 281
Description
Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.